In the present study, we investigated whether the JNK and FADD phosphorylation signals contribute to tamoxifen-induced cell growth arrest in ER-positive breast cancer cells, then tried to execute the signals and effect tumour suppression by using the JNK/FADD activator, paclitaxel, in ER-negative cells. Here, FADD is linked to neoplasm.